327 related articles for article (PubMed ID: 6838301)
1. Rapid and sustained oral theophylline loading. An alternative to intravenous aminophylline therapy.
Brown DL; Maddux MS; Organek HW; Bauman JL
Arch Intern Med; 1983 Apr; 143(4):794-6. PubMed ID: 6838301
[TBL] [Abstract][Full Text] [Related]
2. The design of oral sustained-release theophylline dosing after conversion from intravenous to oral therapy.
Yamazaki M; Fukutomi O; Kondo N; Kato Z; Nakashima Y; Shinoda S; Agata H; Kondo T; Imaeda N; Orii T
Int J Clin Pharmacol Ther; 1994 Nov; 32(11):625-31. PubMed ID: 7874380
[TBL] [Abstract][Full Text] [Related]
3. Sustained-release theophylline. Pharmacokinetic and therapeutic comparison of two preparations.
Menendez R; Kelly HW; Howick J; McWilliams BC
Am J Dis Child; 1983 May; 137(5):469-73. PubMed ID: 6846276
[TBL] [Abstract][Full Text] [Related]
4. Intersubject variability of serum theophylline concentration after single dose of uncoated controlled release theophylline tablet administration in asthmatic patients.
Raj NS; Guleria R; Misra A; Pande JN
Indian J Chest Dis Allied Sci; 1997; 39(3):143-7. PubMed ID: 9357147
[TBL] [Abstract][Full Text] [Related]
5. Serum theophylline levels in asthmatic children receiving sustained-release theophylline tablets.
Kelly HW; Murphy S
Am J Hosp Pharm; 1979 Dec; 36(12):1698-701. PubMed ID: 525646
[TBL] [Abstract][Full Text] [Related]
6. Conversion from intravenous aminophylline to sustained-release theophylline: computer simulation versus in vivo results.
Hatton RC; Gotz VP; Robinson JD; Russell WL; Ryerson GG
Clin Pharm; 1983; 2(4):347-52. PubMed ID: 6883961
[TBL] [Abstract][Full Text] [Related]
7. Comparison of serum theophylline levels in asthmatic children receiving sustained-release and rapid-release theophylline tablets.
Beer S; Laver J; Benson L; Cotariu D; Neli P; Saidman JL; Viure E
Isr J Med Sci; 1982 Feb; 18(2):255-8. PubMed ID: 7068356
[TBL] [Abstract][Full Text] [Related]
8. Effect of meals and dosage-form modification on theophylline bioavailability from a 24-hour sustained-release delivery system.
González MA; Straughan AB
Clin Ther; 1994; 16(5):804-14. PubMed ID: 7859239
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of serum theophylline concentrations following administration of sustained-release beads in applesauce to asthmatic preschool children.
Leeder JS; Robertson C; Correia J; Isles AF; Levison H; Macleod SM
Ann Allergy; 1986 Feb; 56(2):133-7. PubMed ID: 3946845
[TBL] [Abstract][Full Text] [Related]
10. The influence of enteral feedings on sustained-release theophylline absorption.
Plezia PM; Thornley SM; Kramer TH; Armstrong EP
Pharmacotherapy; 1990; 10(5):356-61. PubMed ID: 2122422
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of long-term oral administration of a sustained release theophylline preparation in children with chronic asthma.
Cantani A; Businco E; Businco L; Solano A; Calabretta C
Allergol Immunopathol (Madr); 1983; 11(1):11-4. PubMed ID: 6858803
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic comparison of a once-daily and twice-daily theophylline delivery system.
González MA; Kisicki J; Straughn AB
Clin Ther; 1994; 16(4):686-92. PubMed ID: 7982257
[TBL] [Abstract][Full Text] [Related]
13. Theophylline administration in children with asthma: optimal pulmonary function and possible tolerance to chronic administration.
Katz RM; Rachelefsky GS; Siegel SC; Mickey R
Ann Allergy; 1983 Jan; 50(1):23-6. PubMed ID: 6849515
[TBL] [Abstract][Full Text] [Related]
14. Absorption of theophylline from conventional and sustained-release tablets.
Mellstrand T; Svedmyr N; Fagerström PO
Eur J Respir Dis Suppl; 1980; 109():54-60. PubMed ID: 6934088
[TBL] [Abstract][Full Text] [Related]
15. Theophylline levels after single daily and divided dosing of a once-a-day theophylline preparation in asthmatic children.
Boner AL; Sette L; Vallone G; Plebani M; Messori A
Ann Allergy; 1989 Feb; 62(2):149-53. PubMed ID: 2919803
[TBL] [Abstract][Full Text] [Related]
16. Variations in absorption of theophylline from two sustained-release products.
Ferrari M; Olivieri M; Barozzi E; Ramponi C
Clin Ther; 1986; 8(6):646-54. PubMed ID: 3791362
[TBL] [Abstract][Full Text] [Related]
17. Absorption of theophylline from conventional and sustained-release tablets.
Fagerström PO; Mellstrand T; Svedmyr N
Int J Clin Pharmacol Ther Toxicol; 1981 Mar; 19(3):131-8. PubMed ID: 7228455
[TBL] [Abstract][Full Text] [Related]
18. Conversion from intravenous to oral dosing using sustained-release theophylline tablets.
Stein GE; Haughey DB; Ross RJ; Vakoutis J
Drug Intell Clin Pharm; 1982 Oct; 16(10):772-4. PubMed ID: 7140514
[TBL] [Abstract][Full Text] [Related]
19. Clinical utility of the single point method for theophylline maintenance dose prediction.
Abad J; Pastor A; Prieto L; Palop J; Jiménez Torres V; Castro J
Allergol Immunopathol (Madr); 1987; 15(6):355-9. PubMed ID: 3445876
[TBL] [Abstract][Full Text] [Related]
20. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
Schuppan D; Molz KH; Staib AH; Rietbrock N
Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
